280 related articles for article (PubMed ID: 14645322)
1. Relationships among various nucleoside resistance-conferring mutations in the reverse transcriptase of HIV-1.
Turner D; Brenner B; Wainberg MA
J Antimicrob Chemother; 2004 Jan; 53(1):53-7. PubMed ID: 14645322
[TBL] [Abstract][Full Text] [Related]
2. Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors.
Domaoal RA; Demeter LM
Int J Biochem Cell Biol; 2004 Sep; 36(9):1735-51. PubMed ID: 15183341
[TBL] [Abstract][Full Text] [Related]
3. Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Alcaro S; Alteri C; Artese A; Ceccherini-Silberstein F; Costa G; Ortuso F; Parrotta L; Perno CF; Svicher V
Drug Resist Updat; 2011 Jun; 14(3):141-9. PubMed ID: 21295512
[TBL] [Abstract][Full Text] [Related]
4. The emergence and epidemiology of resistance in the nucleoside-experienced HIV-infected population.
Pillay D
Antivir Ther; 2001; 6 Suppl 3():15-24. PubMed ID: 11678470
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
Martinez-Picado J; Martínez MA
Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
[TBL] [Abstract][Full Text] [Related]
6. Nucleoside-analog resistance mutations in HIV-1 reverse transcriptase and their influence on polymerase fidelity and viral mutation rates.
Rezende LF; Prasad VR
Int J Biochem Cell Biol; 2004 Sep; 36(9):1716-34. PubMed ID: 15183340
[TBL] [Abstract][Full Text] [Related]
7. Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.
Escoto-Delgadillo M; Vázquez-Valls E; Ramírez-Rodríguez M; Corona-Nakamura A; Amaya-Tapia G; Quintero-Pérez N; Panduro-Cerda A; Torres-Mendoza BM
HIV Med; 2005 Nov; 6(6):403-9. PubMed ID: 16268822
[TBL] [Abstract][Full Text] [Related]
8. Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.
Zhang Z; Walker M; Xu W; Shim JH; Girardet JL; Hamatake RK; Hong Z
Antimicrob Agents Chemother; 2006 Aug; 50(8):2772-81. PubMed ID: 16870771
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase.
Menéndez-Arias L
Virus Res; 2008 Jun; 134(1-2):124-46. PubMed ID: 18272247
[TBL] [Abstract][Full Text] [Related]
10. Differences between semen and plasma of nucleoside reverse transcriptase resistance mutations in HIV-infected patients, using a rapid assay.
Liuzzi G; Chirianni A; Zaccarelli M; Zinzi D; Esposito V; Guadagnino V; Antinori A; Piazza M
In Vivo; 2004; 18(4):509-12. PubMed ID: 15369193
[TBL] [Abstract][Full Text] [Related]
11. [Impacts of HIV-1 resistance mutations associated with nucleoside reverse transcriptase inhibitors on viral fitness].
Zhou Q; Liao LJ; Huang HJ
Bing Du Xue Bao; 2012 May; 28(3):291-6. PubMed ID: 22764534
[TBL] [Abstract][Full Text] [Related]
12. The K65R mutation in HIV-1 reverse transcriptase.
Winston A; Stebbing J
J HIV Ther; 2004 May; 9(2):25-7. PubMed ID: 15238872
[No Abstract] [Full Text] [Related]
13. Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors.
Tambuyzer L; Azijn H; Rimsky LT; Vingerhoets J; Lecocq P; Kraus G; Picchio G; de Béthune MP
Antivir Ther; 2009; 14(1):103-9. PubMed ID: 19320243
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients.
Wirden M; Lambert-Niclot S; Marcelin AG; Schneider L; Ait-Mohand H; Brunet C; Angleraud F; Amard S; Katlama C; Calvez V
AIDS; 2009 Jan; 23(1):95-9. PubMed ID: 19050391
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
Liu J; Yue J; Wu S; Yan Y
Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
[TBL] [Abstract][Full Text] [Related]
16. The rationale for a study on HIV-1 reverse transcriptase mutations and outcome of antiretroviral therapy with two nucleoside analogs.
Gianotti N; Moretti F; Tambussi G; Capiluppi B; Ferrari M; Lazzarin A
J Biol Regul Homeost Agents; 1999; 13(3):158-62. PubMed ID: 10560749
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of HIV-1 polymerase gene mutations in pre-treated patients in Thailand.
Chantratita W; Jenwitheesuk E; Watitpun C; Pongthanapisith V; Vibhagool A; Leechawengwong M; Sookpranee M; Apairatana A
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):80-4. PubMed ID: 12118466
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
[TBL] [Abstract][Full Text] [Related]
19. Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants.
Dykes C; Fox K; Lloyd A; Chiulli M; Morse E; Demeter LM
Virology; 2001 Jul; 285(2):193-203. PubMed ID: 11437654
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing.
Reinis M; Vandasová J; Stanková M; Linka M; Brůcková M
Acta Virol; 2001; 45(5-6):279-86. PubMed ID: 12083326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
